While Altria Group is a staple in many portfolios for its dependable dividend, recent regulatory filings have drawn investor scrutiny....

Investor focus returns to Viking Therapeutics next week as company executives prepare to outline their strategic vision at two major...

The digital payments giant PayPal finds itself navigating turbulent waters. A disappointing quarterly earnings release, a sudden change in leadership,...

CrowdStrike Holdings, Inc. has delivered a powerful one-two punch, combining a landmark European partnership with exceptional quarterly and annual financial...

In a bold maneuver within the challenging U.S. housing market, Opendoor Technologies is reviving its mortgage lending operations. The iBuyer...

In a significant breakthrough for its public sector ambitions, Workday has announced a major contract win with the U.S. Department...

The clinical-stage biotech firm Replimune is advancing its lead therapeutic candidate with a clear emphasis on navigating regulatory requirements. The...

Adobe enters a pivotal week, with its quarterly results scheduled for March 12. Investors are keenly watching to see if...

Nvidia has halted production of its H200 artificial intelligence chips destined for the Chinese market, a strategic pivot driven by...

All eyes are on Oracle this week as the technology giant prepares to release its quarterly earnings. The report, due...